JP2017527553A5 - - Google Patents

Download PDF

Info

Publication number
JP2017527553A5
JP2017527553A5 JP2017509637A JP2017509637A JP2017527553A5 JP 2017527553 A5 JP2017527553 A5 JP 2017527553A5 JP 2017509637 A JP2017509637 A JP 2017509637A JP 2017509637 A JP2017509637 A JP 2017509637A JP 2017527553 A5 JP2017527553 A5 JP 2017527553A5
Authority
JP
Japan
Prior art keywords
blood
vitro
calcium
bsp
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017509637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017527553A (ja
JP6675383B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/069098 external-priority patent/WO2016026917A2/en
Publication of JP2017527553A publication Critical patent/JP2017527553A/ja
Publication of JP2017527553A5 publication Critical patent/JP2017527553A5/ja
Priority to JP2020039561A priority Critical patent/JP6968220B2/ja
Application granted granted Critical
Publication of JP6675383B2 publication Critical patent/JP6675383B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017509637A 2014-08-19 2015-08-19 慢性腎疾患の治療のための医薬および装置 Active JP6675383B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020039561A JP6968220B2 (ja) 2014-08-19 2020-03-09 慢性腎疾患の治療のための医薬および装置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102014111859 2014-08-19
DE102014111859.6 2014-08-19
PCT/EP2015/069098 WO2016026917A2 (en) 2014-08-19 2015-08-19 Medicament and apparatus for treating chronic kidney disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020039561A Division JP6968220B2 (ja) 2014-08-19 2020-03-09 慢性腎疾患の治療のための医薬および装置

Publications (3)

Publication Number Publication Date
JP2017527553A JP2017527553A (ja) 2017-09-21
JP2017527553A5 true JP2017527553A5 (enExample) 2018-09-13
JP6675383B2 JP6675383B2 (ja) 2020-04-01

Family

ID=54014792

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017509637A Active JP6675383B2 (ja) 2014-08-19 2015-08-19 慢性腎疾患の治療のための医薬および装置
JP2020039561A Active JP6968220B2 (ja) 2014-08-19 2020-03-09 慢性腎疾患の治療のための医薬および装置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020039561A Active JP6968220B2 (ja) 2014-08-19 2020-03-09 慢性腎疾患の治療のための医薬および装置

Country Status (6)

Country Link
US (2) US10253092B2 (enExample)
EP (1) EP3182995B1 (enExample)
JP (2) JP6675383B2 (enExample)
AU (1) AU2015306108B2 (enExample)
CA (1) CA2958263C (enExample)
WO (1) WO2016026917A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2958263C (en) * 2014-08-19 2022-12-13 Immundiagnostik Ag Medicament and apparatus for treating chronic kidney disease
EP3924735A1 (en) 2019-02-15 2021-12-22 Immundiagnostik AG Rapid test for diagnosis of bacterial infections in neonates
EP4028418A1 (en) * 2019-09-14 2022-07-20 Immundiagnostik AG Medicinal preparation for treating fibrosis with anti bsp antibodies
WO2021226064A1 (en) * 2020-05-04 2021-11-11 University Of Louisville Research Foundation, Inc. Artificial intelligence-based systems and methods for dosing of pharmacologic agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0337075A (ja) * 1989-07-04 1991-02-18 Baiteku Res:Kk 抗体固定担体、その製造方法およびその用途
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
JP3329868B2 (ja) * 1992-09-30 2002-09-30 株式会社クラレ ペプチドおよびこれを担体上に固定化してなる吸着剤
CA2355228A1 (en) 1998-12-22 2000-06-29 University Of Virginia Patent Foundation Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
US7790853B2 (en) * 2001-06-13 2010-09-07 Franz Paul Armbruster Determination of bone-sialoprotein in bodily fluids for oncological problems
ES2336770T3 (es) * 2001-06-13 2010-04-16 Armbruster Biotechnology Gmbh Medicamentos para el tratamiento de tumores y sus metastasis utilizando una molecula de union contra la sialoproteina osea.
JP4177702B2 (ja) * 2003-04-28 2008-11-05 株式会社三重ティーエルオー 血液浄化用吸着材及びそれを用いたＩｇＡ腎症治療システム
WO2011000086A1 (en) 2009-07-03 2011-01-06 The Governors Of The University Of Alberta Method and apparatus for reducing serum phosphate in hemodialysis patients
EP2558177A1 (en) * 2010-04-15 2013-02-20 Fresenius Medical Care Holdings, Inc. Anticoagulant-free dialysis systems and methods
CA2958263C (en) * 2014-08-19 2022-12-13 Immundiagnostik Ag Medicament and apparatus for treating chronic kidney disease

Similar Documents

Publication Publication Date Title
Yumoto et al. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration
Sanchez et al. The selective therapeutic apheresis procedures
CN103781500B (zh) 用于患者解毒的靶向磁性增强系统
JP2010507432A5 (enExample)
PT1949915E (pt) Método e sistema para remover rfnt1,rfnt2, e ril2 solúveis em pacientes
Dima et al. Management of relapsed–refractory multiple myeloma in the era of advanced therapies: evidence-based recommendations for routine clinical practice
HRP20250164T1 (hr) Inhibitorna monoklonska antitijela protiv faktora xii/xiia i njihove uporabe
JP2013530986A (ja) 体液および組織からの選択された分子の一段階除去
US20110160636A1 (en) Device and method for inhibiting complement activation
JP2012533582A5 (enExample)
Huang et al. Nanobody-Based high-performance immunosorbent for selective beta 2-microglobulin purification from blood
US20180093032A1 (en) Targeted apheresis using binding agents or ligands immobilized on membranes
JP6968220B2 (ja) 慢性腎疾患の治療のための医薬および装置
WO2020176683A1 (en) Whole blood treatment device and methods of removing target agents from whole blood
JP2020527155A (ja) ガイダンス分子薬物複合体の連続製造
WO2018020285A4 (en) Flow capture device and method for removing cells from blood
Yoo et al. Role of plasma exchange in ABO-incompatible kidney transplantation
Forni et al. Extracorporeal renal replacement therapies in the treatment of sepsis: where are we?
García-Villegas et al. Hemoadsorption in organ preservation and transplantation: a narrative review
Saito et al. Removal of Aβ oligomers from the blood: a potential therapeutic system for Alzheimer’s disease
Lezhnina et al. Application of extracorporeal apheresis in treatment of COVID-19: A rapid review
US6030614A (en) Ameliorating immunological rejection of allograft
Ptak et al. Immunoadsorption therapy and complement activation
JP7255899B2 (ja) 組織または流体から分子を選択的に除去するためのデバイス
US12390569B2 (en) Simplified regeneration of apheresis columns